P2RX7 and colorectal carcinoma: The finding that blockade of P2X7-dependent vesicular release can prevent CRC dissemination is of particular relevance given that although inhibition of extracellular vesicle secretion holds promise for preventing tumor progression [48], no drugs that target vesicular secretion have been approved for human use [22, 49].